Want to join the conversation?
$VRTX's revenues increased significantly in 2015 as compared to 2014, primarily due to cystic fibrosis treating drug Orkambi net product revenues, which commenced in 3Q15, and a $167.9MM increase in Kalydeco net product revenues, partially offset by a $43.6MM decrease in its collaborative revenues.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.